Status:

UNKNOWN

Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer

Lead Sponsor:

National Cancer Institute, Naples

Conditions:

Ovarian Cancer

Eligibility:

FEMALE

18+ years

Phase:

PHASE3

Brief Summary

The purpose of this study is to study efficacy and the effects on quality of life in women with ovarian cancer treated with a weekly schedule of chemotherapy with carboplatin and paclitaxel compared t...

Detailed Description

The standard first-line treatment of ovarian cancer is combination chemotherapy with carboplatin and paclitaxel, given every 3 weeks. Researchers are looking at new ways of giving chemotherapy to make...

Eligibility Criteria

Inclusion

  • Cytologic or histologic diagnosis of ovarian carcinoma of the ovary, fallopian tube or primary peritoneal carcinoma, stage IC-IV
  • Indication for chemotherapy
  • Age \> 18 years
  • Life expectancy of at least 3 months

Exclusion

  • Previous or concomitant malignant malignancy (excluding adequately treated baso-or squamocellular carcinoma of the skin and carcinoma in situ of the cervix, and synchronous endometrioid carcinoma Stage Ib or less for the uterus, with ovarian tumor Stage II or higher)
  • Performance Status (ECOG) \> or = 3.
  • Previous chemotherapy
  • Heart disease (congestive heart failure, myocardial infarction within 6 months from study entry, atrioventricular block of any grade, severe arrhythmias)
  • Neutrophils \< 2000 x mm3, platelets \< 100000 x mm3
  • Inadequate renal function (creatinine \> or = 1.25 x normal values) or liver function (ALT or AST \> or = 1.25 x normal values)
  • Present or suspected hemorrhagic syndromes
  • Inability to comply with protocol and follow-up
  • Inability to access study site for clinical visits
  • Refusal of informed consent

Key Trial Info

Start Date :

November 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2024

Estimated Enrollment :

800 Patients enrolled

Trial Details

Trial ID

NCT00660842

Start Date

November 1 2008

End Date

November 1 2024

Last Update

March 24 2023

Active Locations (28)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 7 (28 locations)

1

IRCCS Oncologico Bari, Oncologia Medica

Bari, BA, Italy, 70126

2

Ospedale Riuniti di Bergamo, U.O. di Ostetricia e Ginecologia

Bergamo, BG, Italy, 24128

3

Ospedale Fatebenefratelli, U.O. di Oncologia

Benevento, BN, Italy, 82100

4

Azienda Ospedaliera G. Rummo

Benevento, BN, Italy